A. Gonorrhea

B. AIDS

D. Syphilis

B. Serum SGPT

C. Serum SGOT

D. Serum CPK

A. Hyperplasia

B. Hypertrophy

D. None of the above

B. Wasserman reaction

C. Mituda reaction

D. None of the above

A. A decrease in the central venous pressure

B. A decrease in the blood pressure

C. A decrease in the urine output

A. Arterial thrombi produces ischemia and infarction where as cardiac and venous thrombi cause embolism

C. Arterial thrombi to be white and non occlusive (mural) where as venous thrombi are red and occlusive

D. Venous thrombi are soft, red and gelatinous where as arterial thrombi are firm and white

B. Rough endoplasmic reticulum

C. None of the above

D. RNA template

A. Adenomas

B. Adenosarcomas

C. Angiomas

A. Leprosy

B. Sarcoidosis

D. Tuberculosis

A. G6PD

C. Dengue fever

D. Thalassemia

B. Oncogene

C. Bacterial antigen

D. Proto oncogene

B. Epstein Barr virus

C. papilloma virus

D. Hepatitis B virus

A. Macrophages

B. Lymphocytes

D. Plasma cells

A. 2

B. 9

C. 6

A. Heart

C. Kidney

D. Liver

A. Gorlin syndrome

C. Holoprosencephaly

D. Mayer Rokitansky syndrome

A. Skeletal muscle

B. Cardiac muscle

D. Neurons

A. Hemothorax

B. Heamoperitonium

D. Heamopericardium

A. Ecchymosis

C. Malena

D. Petechiae

A. Systemic venous congestion

B. Oedematous ankles

D. Enlargement of spleen and liver

A. Epidermoid carcinoma

B. Basal cell carcinoma

D. Melanoma

A. Foliate deficiency anemia

B. Pernicious anemia

C. Vitamin B12 deficiency anemia

A. Turner syndrome

C. Trisomy 18

D. Trisomy 21

A. Vitamin C

C. Myofibroblasts

D. Fibroblasts

B. Cytopathic

C. Exudative

D. Necrotizing

B. Infectious mononcleosis

C. Osteoporosis

D. T cell tumour

A. Intestines

B. Heart

C. Kidneys

A. Neutrophilic infiltration

C. Ingress of macrophages

D. Intense eosinophilia

A. Hematoma

B. Papilloma

C. Lymphosarcoma

A. Hypodontia

B. Differentiation

D. Hyperplasia

A. Go G1 S M G2

B. Go M G2 S G1

C. Go G1 G2 S M

B. Aorta Aneurysm, thromboembolism

C. Heart MI, Ischemic heart disease

D. Lower extremities claudication gangrene

B. 0.06 mg

C. 60 mg

D. 600 mg

A. None of the above

B. Ossifying fibroma

C. Fibrous dysplasia

A. Kidney

C. Spleen

D. Heart

A. Hypovolemia

B. Vasoconstriction

D. Sepsis

A. D-tubocurarine

B. Gallamine triethiodide

C. Pancuronium bromide

B. Exprss MHC class I proteins

C. Unable to express MHC class II proteins

D. Express MHC class II proteins

A. 46 X Y, -14 t(14;21)

C. 47 X &, (+2)

D. 47 X Y, -14 t(14;21)

A. Eosinophils

B. Neutrophils

D. Normoblats

A. choline, adrenaline and amphetamine

B. Glycinium neostigamine and physostigamine

C. Pirenzipine, propanolol and propantheline

B. Dysplasia

C. Anaplasia

D. Normal histology

A. Specific gravity of above 1.018

B. Tendency to clot

D. Associated inflammatory conditions

A. Trisomy of 21 chromosome

B. Robersonian translocation of 21.21, 21.18

D. Mosaicism of 21 chromosome

A. In basal layers of epithelium

B. In surface layers only

D. None of the above

A. Keloid

B. Cicatrisation

C. Wound dehiscence

A. LxB4

C. LxA4

D. 5-HETE

A. The central venous pressure ins high

C. Urine output is unaffected

D. There is always s site of bleeding

A. Blushing

B. Inflammation

C. Muscles during exercise

B. Renal arteries

C. Cerebral arteries

D. Coronary arteries